SI20974A - Alkoksi substituirane benzimidazolne spojine, farmacevtski pripravki, ki jih vsebujejo ter metode za njihovo uporabo - Google Patents

Alkoksi substituirane benzimidazolne spojine, farmacevtski pripravki, ki jih vsebujejo ter metode za njihovo uporabo Download PDF

Info

Publication number
SI20974A
SI20974A SI200020039A SI200020039A SI20974A SI 20974 A SI20974 A SI 20974A SI 200020039 A SI200020039 A SI 200020039A SI 200020039 A SI200020039 A SI 200020039A SI 20974 A SI20974 A SI 20974A
Authority
SI
Slovenia
Prior art keywords
methoxy
formula
compounds
methyl
sulfinyl
Prior art date
Application number
SI200020039A
Other languages
English (en)
Slovenian (sl)
Inventor
Robert Whittle
Frederick D. Sancilio
Grayson Walker Stowell
Douglas John Jenkins
Linda Whittall
Glenn Alan Meyer
Steven A. Fontana
Original Assignee
Aaipharma, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/519,976 external-priority patent/US6262085B1/en
Application filed by Aaipharma, Inc. filed Critical Aaipharma, Inc.
Publication of SI20974A publication Critical patent/SI20974A/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
SI200020039A 1999-08-26 2000-08-25 Alkoksi substituirane benzimidazolne spojine, farmacevtski pripravki, ki jih vsebujejo ter metode za njihovo uporabo SI20974A (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15087899P 1999-08-26 1999-08-26
US09/519,976 US6262085B1 (en) 1999-08-26 2000-03-07 Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
PCT/US2000/023363 WO2001014367A1 (en) 1999-08-26 2000-08-25 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same

Publications (1)

Publication Number Publication Date
SI20974A true SI20974A (sl) 2003-02-28

Family

ID=26848119

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200020039A SI20974A (sl) 1999-08-26 2000-08-25 Alkoksi substituirane benzimidazolne spojine, farmacevtski pripravki, ki jih vsebujejo ter metode za njihovo uporabo

Country Status (16)

Country Link
EP (1) EP1206466B1 (xx)
JP (1) JP4312405B2 (xx)
KR (1) KR100712039B1 (xx)
CN (2) CN1183127C (xx)
AT (1) ATE306483T1 (xx)
AU (2) AU777667B2 (xx)
BR (1) BR0014145A (xx)
CA (1) CA2382867A1 (xx)
DE (1) DE60023154T2 (xx)
HR (1) HRP20020174A2 (xx)
MX (1) MXPA02002007A (xx)
NO (1) NO326849B1 (xx)
RO (1) RO122491B1 (xx)
RU (1) RU2263673C2 (xx)
SI (1) SI20974A (xx)
SK (1) SK286903B6 (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2376231A (en) * 2001-06-06 2002-12-11 Cipla Ltd Benzimidazole-cyclodextrin inclusion complex
MXPA06015031A (es) * 2004-06-24 2007-02-08 Astrazeneca Ab Nuevo proceso para la preparacion de modificaciones cristalinas para usarse en la preparacion de sal de sodio de esomeprazol.
ES2246149B1 (es) * 2004-07-02 2007-06-01 Esteve Quimica, S.A. Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.
CN103524491A (zh) * 2013-10-16 2014-01-22 江南大学 埃索美拉唑镁盐四水合物的三种晶型及其制备方法
CN114558004B (zh) * 2022-03-29 2023-08-11 奎马特里克斯有限公司 Qtx125药物制剂
CN118225938B (zh) * 2024-04-02 2024-08-30 江苏海洋大学 一种中药复方五神汤的质量检测方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds

Also Published As

Publication number Publication date
KR20020035861A (ko) 2002-05-15
RO122491B1 (ro) 2009-07-30
NO20020914L (no) 2002-04-26
EP1206466B1 (en) 2005-10-12
AU777667B2 (en) 2004-10-28
CN1384831A (zh) 2002-12-11
NO326849B1 (no) 2009-03-02
CN1183127C (zh) 2005-01-05
AU2005200203A1 (en) 2005-02-10
DE60023154T2 (de) 2006-06-22
RU2263673C2 (ru) 2005-11-10
HRP20020174A2 (en) 2005-12-31
MXPA02002007A (es) 2003-08-20
JP4312405B2 (ja) 2009-08-12
DE60023154D1 (de) 2006-02-23
CA2382867A1 (en) 2001-03-01
AU7073700A (en) 2001-03-19
CN1636564A (zh) 2005-07-13
KR100712039B1 (ko) 2007-04-27
BR0014145A (pt) 2002-05-14
JP2003507475A (ja) 2003-02-25
SK286903B6 (sk) 2009-07-06
EP1206466A1 (en) 2002-05-22
SK2812002A3 (en) 2002-07-02
AU2005200203B2 (en) 2008-01-10
ATE306483T1 (de) 2005-10-15
NO20020914D0 (no) 2002-02-25

Similar Documents

Publication Publication Date Title
US6667321B2 (en) Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6268385B1 (en) Dry blend pharmaceutical formulations
WO2001014367A1 (en) Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6262086B1 (en) Pharmaceutical unit dosage form
US6326384B1 (en) Dry blend pharmaceutical unit dosage form
US20050214372A1 (en) Stable pharmaceutical composition comprising an acid labile drug
US20100286400A1 (en) Crystalline solvated forms of (r)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1h-benzimidazole
AU2005200203B2 (en) Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
EP1018340B1 (en) Inclusion aminoacid salts compounds of benzimidazole derivatives with cyclodextrins, their preparation and pharmaceutical formulations containing them
US6312723B1 (en) Pharmaceutical unit dosage form
US6316020B1 (en) Pharmaceutical formulations
US6312712B1 (en) Method of improving bioavailability
EP1595879A2 (en) Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same

Legal Events

Date Code Title Description
IF Valid on the event date
KO00 Lapse of patent

Effective date: 20100507